Paraskevi Giannakakou

Also affiliated with Lander Institute, Weill Cornell Medicine

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

File S1 from Circulating Tumor Cell Genomic Evolution and Hormone Therapy Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer

(2023)10.1158/1541-7786.22527275

Top 100%

0DataRank

Top 100%0 citations

Susan Halabi, Gábor Kemény, Monika Anand, Paraskevi Giannakakou, David M. Nanus +4 more

Papers

Driven by 18 papers — median percentile 0. Top paper: “CLIP-170S is a microtubule +TIP variant that confers resistance to taxanes by impairing drug-target engagement”.

CLIP-170S is a microtubule +TIP variant that confers resistance to taxanes by impairing drug-target engagement

Developmental Cell(2021)10.1016/j.devcel.2021.09.023

N/A

0.593DataRank · unranked

13 citations

Katsuhiro Kita, Urko del Castillo, Giuseppe Galletti, Neel S. Madhukar, Elena Vila Navarro +11 more

Association of circulating tumor cell chromosomal instability with worse outcomes in men with mCRPC treated with abiraterone or enzalutamide.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.183

N/A

0.165DataRank · unranked

2 citations

Susan Halabi, Joseph D. Schonhoft, Jun Luo, David M. Nanus, Paraskevi Giannakakou +13 more

Multicenter Phase II Study of Cabazitaxel in Advanced Gastroesophageal Cancer: Association of HER2 Expression and M2-Like Tumor-Associated Macrophages with Patient Outcome

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3920

N/A

0DataRank · unranked

13 citations

Peter C. Enzinger, Andrew Ko, Allyson J. Ocean, Philip Agop Philip, Prashant V. Thakkar +20 more

Quantitative analysis of taxane drug target engagement of microtubules in circulating tumor cells from metastatic castration resistant prostate cancer patients treated with CRXL301, a nanoparticle of docetaxel

Cancer Drug Resistance(2020)10.20517/cdr.2019.116

N/A

0DataRank · unranked

6 citations

Daniel Worroll, Giuseppe Galletti, Shelly Schuster, Sarina A. Piha‐Paul, Paraskevi Giannakakou +1 more

AR-V7 and prediction of benefit with taxane therapy: Final analysis of PROPHECY.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.184

N/A

0DataRank · unranked

1 citations

Jun Luo, Monika Anand, Emmanuel S. Antonarakis, David M. Nanus, Paraskevi Giannakakou +10 more

Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-3471

N/A

0DataRank · unranked

37 citations

Susan Halabi, Joseph D. Schonhoft, Qian Yang, Jun Luo, David M. Nanus +19 more

AR-V7 exhibits non-canonical mechanisms of nuclear import and chromatin engagement in Castrate-Resistant Prostate Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.06.03.446940

N/A

0DataRank · unranked

2 citations

Mohd Azrin Bin Jamalruddin, CheukMan C. Au, Eiman Mukhtar, Luigi Portella, Adeline Berger +5 more

Liquid-biopsy transcriptomic profiling uncovers molecular mediators of resistance to androgen receptor signaling inhibition in lethal prostate cancer

medRxiv(2021)10.1101/2021.11.01.21265757

N/A

0DataRank · unranked

2 citations

Bob Zimmermann, Giuseppe Galletti, Susan Halabi, Ada Gjyrezi, Qian Yang +16 more

Phase I/II trial of pembrolizumab and AR signaling inhibitor +/- 225Ac-J591 for chemo-naive metastatic castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.tps216

N/A

0DataRank · unranked

9 citations

Joseph R. Osborne, Matthew C. Dallos, Jones T. Nauseef, Cora N. Sternberg, Peter Gregos +11 more

Data from The Synergistic Combination of the Farnesyl Transferase Inhibitor Lonafarnib and Paclitaxel Enhances Tubulin Acetylation and Requires a Functional Tubulin Deacetylase

(2023)10.1158/0008-5472.c.6494576

N/A

0DataRank · unranked

0 citations

Jun Zhou, Aurora O’Brate, Ernest Hamel, Jason W.H. Wong, Michael C. Nivens +5 more

Data from The Synergistic Combination of the Farnesyl Transferase Inhibitor Lonafarnib and Paclitaxel Enhances Tubulin Acetylation and Requires a Functional Tubulin Deacetylase

(2023)10.1158/0008-5472.c.6494576.v1

N/A

0DataRank · unranked

0 citations

Jun Zhou, Aurora O’Brate, Ernest Hamel, Jason W.H. Wong, Michael C. Nivens +5 more

Data from Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide

(2023)10.1158/1078-0432.c.6530474.v1

N/A

0DataRank · unranked

0 citations

Susan Halabi, Joseph D. Schonhoft, Qian Yang, Jun Luo, David M. Nanus +19 more

File S1 from Circulating Tumor Cell Genomic Evolution and Hormone Therapy Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer

(2023)10.1158/1541-7786.22527275

Top 100%

0DataRank

Top 100%0 citations

Susan Halabi, Gábor Kemény, Monika Anand, Paraskevi Giannakakou, David M. Nanus +4 more

APOBEC3A-Induced DNA Damage Drives Polymerase θ Dependency and Synthetic Lethality in Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.10.21.682588

N/A

0DataRank · unranked

1 citations

Weisi Liu, Paul Yoo, Alina Sami, Michal T. Boniecki, Madhura Deshpande +14 more

Aging-dependent dysregulation of EXOSC2 is maintained in cancer as a dependency

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.04.04.647279

N/A

0DataRank · unranked

0 citations

Cheng Zhang, Ezgi Hacisuleyman, Giuseppe Galleti, Chao Wu, Rajasekhar Vinagolu +21 more

Microtubule Engagement with Taxane Is Altered in Taxane-Resistant Gastric Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3018

N/A

0DataRank · unranked

47 citations

Chao Zhang, Ada Gjyrezi, Kyle Cleveland, Jiaren Zhang, Sarah Powell +5 more

Crossroads between autoimmunity and cancer: underlying mechanisms and clinical implications

Physiological Reviews(2025)10.1152/physrev.00012.2025

N/A

0DataRank · unranked

0 citations

Charalampos Skarlis, Clio P. Mavragani, Paraskevi Giannakakou, Ada Gjyrezi

Taxane resistance in prostate cancer is mediated by decreased drug-target engagement

Journal of Clinical Investigation(2020)10.1172/jci132184

N/A

0DataRank · unranked

53 citations

Fang Xie, Olga Voznesensky, Prateek Khanna, Carla Calagua, Yang Bai +11 more

Paraskevi Giannakakou

Indexed papers

Top data-sharing exemplar

Papers